{"id":17119,"type":"page","link":"https:\/\/www.ortaakarsu.net\/?page_id=17119","title":{"rendered":"Apalutamide + Avanafil"},"content":{"rendered":"<p>Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"<p>Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Apalutamide","url":"https:\/\/www.ortaakarsu.net\/?page_id=12325","facts":[{"label":"Active ingredient \/ generic name","value":"apalutamide"},{"label":"ATC code","value":"L02BB05"},{"label":"Administration route","value":"Oral"}]},{"title":"Avanafil","url":"https:\/\/www.ortaakarsu.net\/?page_id=12329","facts":[{"label":"Active ingredient \/ generic name","value":"avanafil"},{"label":"ATC code","value":"G04BE10"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"Revised 10\/2022; DailyMed updated 2024-07-18; 7.2 (Cytochrome P450 Inducers)"}],"sources":[{"label":"STENDRA- avanafil tablet \u2014 US prescribing information","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=fa7d93e3-b69b-4e02-8146-89760cd8e9d6"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:28840","available":true}}